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Abstract FoxM1 (previously named WIN, HFH-11 or Trident)
is a Forkhead box (Fox) transcription factor widely expressed in
proliferating cells. Various findings, including a recent analysis
of FoxM1 knockout mice, suggest that FoxM1 is required for
normal S^M coupling during cell cycle progression. To study the
regulatory role of FoxM1 and its downstream regulatory targets,
three stably transfected HeLa lines that display doxycycline
(dox)-inducible FoxM1 expression were established. Over-
expression of FoxM1 by dox induction facilitates growth
recovery from serum starvation. Quantitation of cyclin B1 and
D1 levels using flow cytometric, Western and Northern analyses
reveals that elevated FoxM1 levels lead to stimulation of cyclin
B1 but not cyclin D1 expression. Transient reporter assays in the
dox-inducible lines and upon co-transfection with a constitutive
FoxM1 expression plasmid suggest that FoxM1 can activate the
cyclin B1 promoter. ß 2001 Federation of European Biochem-
ical Societies. Published by Elsevier Science B.V. All rights
reserved.
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1. Introduction
The cell cycle is a highly regulated event with periods of
DNA replication (S phase) alternating with periods of chro-
mosomal segregation and cell division (M phase). S and M
phases are separated by preparative phases (G1 and G2) but
are tightly coupled so that chromosomal DNA is replicated
precisely once per cell cycle. Failure of this S^M coupling
results in aneuploidy (gain or loss of DNA) leading to abnor-
mality in cell growth and function [1].
Regulation of S^M coupling is best understood in yeast [2].
To maintain stable DNA ploidy in dividing cells, each origin
of replication ¢res only once per cycle and the pre-replication
complex at each origin is only formed after exit from M phase.
Pre-replication complex formation and hence DNA re-repli-
cation is prevented during S, G2 and early M phase by the
inhibitory action of Clb1-4-Cdk1 kinases (yeast equivalents of
mammalian cyclin A-Cdk1 and cyclin B1-Cdk1), which are
also required for triggering M phase. Proteolysis of Clbs at
anaphase terminates Clb1-4-Cdk1 action. In the presence of
Cdc6, pre-replication complexes can be re-formed upon re-
entry into the cell cycle. Therefore, Clb1-4-Cdk1 kinases
play a major role in S^M coupling by suppressing DNA re-
replication and promoting M phase entry.
Cyclin-Cdk activities are partly regulated by periodic
changes in cyclin transcription. Transcriptional regulation of
cyclin synthesis has been extensively studied in yeast Saccha-
romyces cerevisiae due to its powerful genetics. In S. cerevisi-
ae, the activation of G1 cyclins Cln1 and -2 and expression of
S cyclins Clb5 and -6 at START is coordinated by transcrip-
tional complexes SBF (Swi4 and Swi6) and MBF (Swi6 and
Mbp1) reviewed in [3,4]. Another transcriptional complex,
Mcm1/S¡ (Swi ¢ve factor), controls the cell cycle-dependent
expression of the major mitotic cyclin Clb2 [5]. Most recently,
the forkhead/winged helix protein Fkh2 was demonstrated to
be a component of S¡ and deletion of FKH2 was shown to
dramatically reduce CLB2 mRNA levels [6^8]. Much less is
known about the transcriptional regulation of mitotic cyclins
in higher eukaryotes although a recent molecular dissection of
the human cyclin B1 promoter has identi¢ed regions impor-
tant for constitutive and cell cycle-dependent expression of
cyclin B1 [9,10].
In higher eukaryotes, E2Fs have been proposed to be the
mammalian functional homologs of the yeast Mbp1/Swi4/
Swi6 family of proteins because of their critical role in regu-
lating the G1/S checkpoint. Recent structural analyses of the
E2F and Mbp1 DNA binding domains support this related-
ness as both domains display a folding pattern similar to
forkhead/winged helix domains [11,12].
Forkhead box (Fox)M1, previously known as HFH-11, Tri-
dent and FKL16, is a Fox transcription factor expressed ubiq-
uitously in many if not all cell types undergoing proliferation
[13^16]. Several di¡erent lines of evidence suggest that FoxM1
is required for proper cell cycle function. First, in Rat-1 cells
synchronized by serum starvation, FoxM1 levels increase at
the start of DNA replication and persist until the end of
mitosis [16]. Second, Western blots reveal phosphorylation
and degradation of FoxM1 upon entry into M phase [16].
This M phase phosphorylation explains why a 3P partial
FoxM1 cDNA (named MPP2: M Phase Phosphoprotein 2)
was previously isolated in an expression screen for clones
encoding substrates of M phase kinases [17]. The presence
of multiple destruction box sequences (RXXL, X = any amino
acid) at the amino-terminus of FoxM1 suggests that FoxM1,
like mitotic cyclins, is degraded before M phase exit. Third,
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FoxM1/Trident knockout mice generated by Korver et al. [18]
exhibit cell division defects. Homozygous mutant mice die in
the perinatal period and examination of mutant embryos re-
veals DNA polyploidy in cardiomyocytes and hepatocytes.
This ¢nding suggests that FoxM1 is required for normal
S^M coupling of the cell cycle as loss of suppression of
DNA re-replication and/or defects in mitosis are known to
lead to polyploidy. Fourth, transgenic over-expression of
FoxM1/HFH-11 in mice was recently demonstrated to accel-
erate hepatocyte regeneration upon partial hepatectomy [19].
The apparent cell cycle regulatory role in animal models
warrants testing of FoxM1 in cultured cells more amenable
to cell cycle analysis. To investigate the cell cycle regulatory
role of FoxM1 and to identify FoxM1-regulated genes, we
have established several doxycycline (dox)-inducible FoxM1-
expressing HeLa lines. Using these lines, we demonstrate that
over-expression of FoxM1 alters cell cycle kinetics by facili-
tating progression through G2/M. This facilitatory e¡ect is
consistent with maximum levels of FoxM1 detected in cycling
G2/M cells by £ow cytometry. Further study of cyclin expres-
sion using £ow cytometry, Western and Northern blot analy-
ses indicates that FoxM1 activates the expression of cyclin B1
but not of cyclin D1 which explains why FoxM1 over-expres-
sion in HeLa cells accelerates progression through G2/M. Fi-
nally, we show that FoxM1 activates the cyclin B1 promoter
in luciferase reporter gene assays. Our data provide evidence
that FoxM1 exerts its S^M coupling function by regulating
the expression of cyclin B1.
2. Materials and methods
2.1. Generation of FoxM1-inducible HeLa cells
Human FoxM1 cDNA (GenBank accession number U83113) was
PCR-ampli¢ed using a High-Fidelity polymerase (Clontech) for sub-
cloning into the Tet-On1 mammalian expression plasmid pTRE
(Clontech) to generate pTRE-FoxM1. Nucleotide sequence of the
construct was con¢rmed by DNA sequencing. HeLa Tet-On1 cells
(Clontech) were maintained in Dulbecco’s modi¢ed Eagle medium
(Sigma) supplemented with 10% Tet-On1 approved fetal bovine se-
rum (FBS) (Clontech), streptomycin, penicillin and 100 mg/l Genet-
icin0 (Gibco-BRL) at 37‡C in a humidi¢ed atmosphere containing 5%
(v/v) CO2. 40 Wg pTRE-FoxM1 and 2 Wg of the selection plasmid,
pTK-Hyg, were delivered into HeLa Tet-On1 cells by electroporation
(at 950 WF and 0.22 kV/cm). Stably transfected clones were selected
and maintained in the presence of 50 mg/l hygromycin B (Gibco-
BRL) as described by the manufacturer.
2.2. Preparation of cell extracts and analysis by Western blotting
Cells were lysed in denaturing lysis bu¡er (10 mM Tris^HCl, pH
7.4, 1 mM sodium orthovanadate, 1% SDS). Aliquots of cell lysates
were subjected to SDS^PAGE in a 12% Laemmli gel and blotted onto
HyBond1-C Super nitrocellulose membrane (Amersham Pharmacia
Biotech). Anti-MPP2 antibodies (K19 and C20), anti-cyclin B1 (H-
433) and anti-cyclin D1 (R-124) were purchased from Santa Cruz
Biotechnology Inc., Santa Cruz, CA, USA. Anti-MPP2 antibodies
recognize the FoxM1 protein from human, rat and mouse. Antigen^
antibody complexes were detected using a secondary antibody conju-
gated to horseradish peroxidase and visualized using the SuperSignal0
enhanced chemiluminescence detection system (Pierce Chemical).
2.3. Cell proliferation assays, analysis of cell cycle distribution and
cell synchronization
A ¢xed number of cells was seeded onto 24-well culture plates.
After serum starvation overnight, cells were replenished with FBS-
containing culture medium with or without dox (2 Wg/ml). At daily
intervals, cells were trypsinized and those that excluded trypan blue
were counted as viable cells under light microscopy. Cell proliferation
was also assayed using the Cell Proliferation kit (MTT) from Boeh-
ringer Mannheim. Analysis of cell cycle distribution was performed by
£ow cytometry as follows. Ethanol-¢xed cells were treated with
DNase-free RNase followed by propidium iodide (PI) staining (250
Wg/ml in PBS with 1% Triton1 X-100). The PI-stained cells were
detected for far-red £uorescence intensity using the EPICS Elite
ESP high performance cell sorter from Coulter Electronic. Data
were analyzed by the cell cycle analysis software, ModFit LT version
2.0 (Verity software House), to tabulate percentages of cells at G0/G1,
S and G2/M phases. Cell growth was arrested at S phase and at the
G1/S junction by treatment with L-mimosine (0.5 mM) for 16 h in
serum-containing culture medium [20].
2.4. Bivariate antigen-DNA £ow analysis
Cells were ¢xed in ethanol as described above and washed three
times with PBS supplemented with 1% FCS. Fixed cells were immu-
nostained with primary antibodies (against MPP2, cyclin B1 or cyclin
D1) or isotype control IgG followed by the corresponding secondary
antibodies (anti-rabbit IgG for anti-MPP2 and anti-cyclin B1; anti-
mouse IgG for anti-cyclin D1) conjugated with £uorescein isothiocya-
nate (FITC). After antibody binding, cellular DNA was stained with
PI as mentioned above. Cells were detected by FITC and PI £uores-
cence using a 514-nm bandpass ¢lter and 600-nm red pass ¢lter, re-
spectively. Data were interpreted using EXPO21 £ow cytometer anal-
ysis software (Coulter Electronic).
2.5. Transient reporter assays and Northern analysis
The cyclin B1 promoter (3831 to +54; [9,10]) was PCR-ampli¢ed
from HeLa genomic DNA while the cyclin D1 promoter (31179 to
+162; [21]) was subcloned as a 1.34-kb ClaI^NcoI fragment from the
plasmid pRc/ND1-A, which carries a PRAD1 gene fragment. Both
promoter fragments were cloned upstream of the ¢re£y luciferase
reporter gene in pGL3-Basic (Promega). PCR-based mutagenesis of
the cyclin B1 promoter was performed using the Advantage-HF2
PCR kit from Clontech according to Harlow et al. [22]. All constructs
were checked by DNA sequencing. Superfect (Qiagen) and FuGENE
6 (Boehringer) were used as transfection reagents for HeLa and
NIH3T3 cells, respectively. As an internal control for transfection
e⁄ciency, each sample was co-transfected with 2 ng of the Renilla
luciferase vector pRL-SV40. The Promega dual-luciferase reporter
assay system was used to sequentially quantitate ¢re£y and Renilla
luciferases in cell lysates to measure the activity of the tested pro-
moters normalized against the internal control. The CMV pro-
moter-driven expression plasmid, pcDNA3-FoxM1, was constructed
by subcloning the 3.3-kb EcoRI^XhoI FoxM1 fragment excised from
pTRE-FoxM1 into pcDNA3 (Invitrogen). All experiments were con-
ducted in triplicate using independent cultures. For Northern analysis,
total RNAs were isolated using the Trizol reagent (Gibco-BRL) and
separated on 1% agarose^formaldehyde gels, blotted onto HyBond1-
N nylon membrane (Amersham Pharmacia Biotech) and probed with
32P-labelled FoxM1 and cyclin B1 cDNA fragments. Blots were
stripped and reprobed with GAPDH to check for loading di¡erence.
3. Results
3.1. Cell cycle-dependent expression of FoxM1
To examine more closely the cell cycle-dependent expres-
sion of FoxM1 at the single-cell level, expression of FoxM1
protein was quantitated in dividing HeLa cells using bivariate
FoxM1/FITC and DNA/PI £ow cytometric analysis (Fig.
1A,B). This single-cell analysis indicates that FoxM1 expres-
sion is ¢rst initiated in a sub-population of G1 cells, increases
slightly during S phase and reaches peak levels in a subset of
G2/M cells with doubled DNA content (Fig. 1A). The expres-
sion pro¢le is FoxM1-speci¢c as FITC signal could be com-
peted away by pre-incubation with FoxM1 blocking peptide
(Fig. 1B). This strong expression in G2/M supports the S^M
coupling role predicted based on phenotypic analysis of
FoxM1/Trident knockout mice [18].
3.2. Establishment of FoxM1-inducible HeLa cell lines
Disruption of the FoxM1/Trident gene function in mouse
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leads to polyploidy in hepatocytes and cardiomyocytes [18].
This phenotype can be explained by a cell cycle defect in
M phase entry and/or uncontrolled DNA re-replication. How-
ever, Korver et al. [16] could not detect any e¡ect on cell cycle
kinetics by ectopic over-expression of FoxM1/Trident in
transfected cells. To further investigate the cell cycle regula-
tory role of FoxM1 in cultured cells, we set out to condition-
ally over-express FoxM1 in HeLa cells using the Tet-On1-
inducible gene expression systems (Clontech). Multiple human
FoxM1 isoforms have been reported [14,15] ; the FoxM1
cDNA expressed in our cell lines encodes the major ubiqui-
tous isoform (FoxM1c encoded by Class b transcripts as de-
scribed in [14]).
After screening 60 stably transfected HeLa cell lines by
Western blot analysis, we selected three lines (WINH21,
WINH25 and WINH27) displaying FoxM1 expression induc-
ible by dox (a tetracycline derivative) (Fig. 1C, 2 Wg/ml for 24
h). In comparison, the parental HeLa cell line shows no de-
tectable induction of FoxM1 expression (Fig. 1C, lanes 1 and
2). In WINH27, which has the highest basal FoxM1 level
(compare lanes 3, 5 and 7), expression doubles within 4 h of
induction and these high levels persist even 48 h after induc-
Fig. 1. Single-cell analysis of FoxM1 expression and characterization of FoxM1-inducible HeLa lines. A,B: Bivariate £ow cytometric analysis
of FoxM1 expression and cellular DNA content in HeLa cells. FoxM1 was detected in cycling cells by immunostaining with anti-MPP2 anti-
body and FITC-conjugated secondary antibody. Cellular DNA content was measured by PI staining. The doubly stained cells were analyzed
by £ow cytometry as mentioned in Section 2. HeLa cells were immunostained in the absence (A) and presence (B) of a speci¢c blocking peptide
which competes for primary antibody binding. Each spot represents an individual cell with a speci¢c FoxM1 level (y-axis) and DNA content
(x-axis). Identical reference lines were drawn in corresponding panels to assist comparison of expression levels. C,D: Western analysis was con-
ducted to follow dox-inducible FoxM1 over-expression in three stably transfected HeLa lines. C: Time-dependent over-expression of FoxM1.
The HeLa lines, WINH21, WINH25 and WINH27, were treated with dox (2 Wg/ml) and harvested at the indicated time points after dox induc-
tion. Parental HeLa line was used as a negative control. After longer exposure, background level of FoxM1 expression was also detectable in
lanes 1, 2, 3 and 5. D: Dosage-dependent over-expression of FoxM1 in WINH27. WINH27 cells were treated for 24 h with dox at the indi-
cated concentrations (from 0 to 8 Wg/ml). 10 Wg of whole cell lysate was analyzed in each sample as described in Section 2.
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tion (Fig. 1C). Background levels of FoxM1 were also detect-
able in lanes 1, 2, 3 and 5 after longer exposure (data not
shown). FoxM1 induction is dependent on dox concentration;
increase in dox concentration from 0 to 8 Wg/ml gradually
enhances FoxM1 expression in WINH27 (Fig. 1D).
WINH21 shows similar time and dosage dependency in their
dox-mediated FoxM1 over-expression while WINH25 dis-
plays more rapid induction kinetics (data not shown).
3.3. Over-expression of FoxM1 facilitates growth recovery
after serum starvation
To investigate the e¡ect of FoxM1 induction on cell
growth, dox-inducible cell lines were seeded at V10 000
cells/cm2 and serum-starved overnight to slow down initial
cell growth. The number of viable cells per square centimeter
was counted daily for 4 days, using the trypan blue dye ex-
clusion method, in the presence or absence of dox in serum-
containing medium (Fig. 2). A growth facilitatory e¡ect was
observed in both WINH21 and WINH25 after dox induction
(Fig. 2B,C). The greatest e¡ect was detected in WINH27,
which could be seeded at a lower cell density (V3000 cells/
cm2), and dox induction led to a much faster growth recovery
(Fig. 2D). The growth e¡ect in WINH27 became more com-
parable to WINH21 and WINH25 when seeded at V10 000
cells/cm2. The ability of WINH27 but not WINH21 and
WINH25 to survive at lower cell densities may be related to
its higher basal level of FoxM1 expression (Fig. 1). In con-
trast, the control parental HeLa line did not show signi¢cant
growth di¡erence (Fig. 2A) and no signi¢cant cell death was
detectable in any cell line. The e¡ect of dox induction on cell
proliferation could not be observed if the initial serum star-
vation step was omitted. The growth e¡ect was also observed
in a cell proliferation assay (MTT-based) for viable cells (data
not shown).
3.4. FoxM1 induction in synchronized cells facilitates transition
through the G2/M phase
L-Mimosine is a potent inhibitor of DNA replication that
prevents formation of replication forks [20]. To determine the
underlying change in cell cycle kinetics that contributes to
faster growth recovery after serum deprivation, we followed
the growth kinetics of WINH27 cells synchronized at the G1/S
boundary and S phase by L-mimosine treatment. Typically,
after 16 h of drug treatment, V75% of cells became arrested
at the G1/S boundary with around 25% of cells in S phase
(Fig. 3, zero time points). After L-mimosine treatment,
WINH27 cells were placed in serum-free medium with or
without dox and the change in cell cycle distribution was
determined by DNA/PI analysis over a period of 12 h (Fig.
3). The major G1/S population progressed through S phase
with comparable kinetics in both dox-induced and non-in-
duced cells. Interestingly, a new G1 peak (indicated by ar-
rows) corresponding to cells previously in S phase appeared
¢rst in the dox-treated cells after 4 h. However, the corre-
sponding peak in the non-induced cells appeared later and
grew much more slowly. This ¢nding suggests that FoxM1
Fig. 2. Dox-inducible FoxM1 over-expression facilitates growth re-
covery from serum deprivation. The indicated cell clones were se-
rum-starved overnight prior to serum replenishment in the presence
(black bar) or absence (white bar) of dox stimulation (2 Wg/ml) for
an experimental period of four days. The number of viable cells was
counted daily as described in Section 2 and expressed as number of
cells per square centimeter. Results shown are the means þ S.E.M.
of four countings. For each of the three FoxM1-inducible cell lines,
the P-value (calculated by GraphPad Prizm0 software version 2.01)
indicates a signi¢cant di¡erence between the day-4 samples with and
without dox treatment (asterisks).
Fig. 3. FoxM1 over-expression accelerates transition through G2/M. WINH27 cells were synchronized in S phase and at the G1/S junction by
overnight (16 h) administration of L-mimosine (0.5 mM). Thereafter, cells were released from L-mimosine arrest by replenishment with serum-
free medium with (lower panels) or without (upper panels) dox (2 Wg/ml). At indicated time intervals, cells were ¢xed in cold 70% ethanol and
prepared for DNA analysis as described in Section 2. Histograms indicate number of cells (y-axis) plotted against corresponding cellular DNA
content (x-axis). Arrows denote gradual appearance of the new G1 peaks.
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over-expression facilitates progression of cells through G2/M.
Accelerated G2/M progression was also observed in WINH21
and WINH25, but not in the parental HeLa line, similarly
analyzed following cell synchronization (data not shown).
3.5. Over-expression of FoxM1 induces cyclin B1 but not
cyclin D1 expression
To study the molecular basis of FoxM1 action, we analyzed
the e¡ect of FoxM1 over-expression on cyclin expression in
our dox-inducible cell lines. Since endogenous FoxM1 and
cyclin expression is cell cycle-dependent, perturbation of cell
cycle kinetics following FoxM1 over-expression will change
the absolute level of expression of the di¡erent proteins. To
prevent the cell cycle e¡ect of FoxM1 over-expression from
interfering with expression analysis, all cells in subsequent
expression analysis were grown in serum-containing media.
Without serum deprivation, FoxM1 over-expression by dox
induction or transient transfection (see below) did not have
any signi¢cant e¡ect on cell cycle distribution as determined
by £ow cytometry (data not shown).
Because FoxM1 accelerates transition through G2/M, cyclin
B1, a mitotic cyclin, was analyzed with cyclin D1 serving as a
control. Notable di¡erences were observed when we compared
FoxM1 and cyclin protein expression in WINH27 to the pa-
rental HeLa line using bivariate £ow analysis (Fig. 4). The
WINH27 cell line was chosen for this experiment due to its
high basal level of FoxM1 expression relative to the parental
cell line, especially evident in the S and G2/M phases (com-
pare Fig. 4A and B). Concomitant with the elevated FoxM1
levels, there is increased expression of cyclin B1 in the
WINH27 cells relative to the parental HeLa cells, again espe-
cially evident at the S and G2/M phases (Fig. 4C,D) so that
both the FoxM1 and cyclin B1 pro¢les show a smooth curva-
ture at the G1/S junction (see corresponding arrowheads in
Fig. 4B,D). This suggests that FoxM1 may induce cyclin B1
expression. In contrast, cyclin D1 levels appear the same in
WINH27 and the parental cell line, showing that the FoxM1
e¡ect on cyclin B1 is cyclin-speci¢c (Fig. 4E,F). Isotype con-
trols conducted using non-speci¢c antibodies did not reveal
Fig. 4. Comparison of FoxM1 and cyclin expression in WINH27
and parental HeLa cells by bivariate £ow analysis. Dividing paren-
tal HeLa (A,C,E) or WINH27 (B,D,F) cells were ¢xed and immu-
nostained with di¡erent primary antibodies (anti-MPP2 (A,B), anti-
cyclin B1 (C,D) or anti-cyclin D1 (E,F)), followed by the corre-
sponding FITC-conjugated secondary antibodies. After PI staining
to quantitate cellular DNA content, the doubly stained cells were
subjected to £ow analysis as described in Section 2. Expression of
di¡erent proteins was displayed in log scale to reduce scattering at
the y-axis and as a result the FoxM1/DNA pro¢le shown di¡ers
from that of Fig. 1. Identical reference lines were drawn in corre-
sponding panels to aid comparison. Arrowheads (B,D) indicate the
G1/S junctions that show a smooth curvature in WINH27 as a re-
sult of expression increases in S and G2/M cells.
Fig. 5. Dox-induced over-expression of FoxM1 is associated with in-
creased expression of cyclin B1. A,B: Western analysis. WINH25
(A) and WINH27 (B) cells were treated with di¡erent doses of dox
(0^8 Wg/ml) for 9 and 24 h, respectively. Cell lysates were prepared
for Western analysis as described in Section 2. 10 Wg of whole cell
lysate was analyzed in each lane. C,D: Northern analysis. WINH21
(C) and WINH27 (D) cells were subjected to dox treatment of in-
creasing doses to stimulate FoxM1 over-expression. After 24 h, cells
were harvested for Northern analysis and levels of FoxM1 and Cy-
clin B1 transcripts were detected. 20 Wg of total RNA was loaded
per lane. Blots were stripped and reprobed with GAPDH to control
for possible loading di¡erence.
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any di¡erence in background signals between WINH27 and
the parental HeLa line (data not shown).
The inducing e¡ect of FoxM1 on cyclin B1 expression was
also observed in Western blot analysis (Fig. 5). In both
WINH25 and WINH27 cells, induction of FoxM1 expression
resulting from increasing doses of dox was associated with
increased cyclin B1 levels (Fig. 5A,B). Cyclin B1 levels closely
followed the variations in FoxM1 expression while cyclin D1
levels stayed relatively constant. A similar correlation of
FoxM1 and cyclin B1 expression at the RNA level was also
detected in Northern blots (Fig. 5C,D). These data suggest
that FoxM1 as a transcription factor induces cyclin B1 ex-
pression.
3.6. FoxM1 activates the cyclin B1 but not
the cyclin D1 promoter
If FoxM1 is a Fox transcription factor that induces cyclin
B1 expression, it would be expected to activate the cyclin B1
promoter. Both the cyclin B1 and D1 promoters have been
cloned and sequenced, and the transcriptional start sites de-
¢ned [9,10,21]. To study the e¡ect of FoxM1 over-expression
on the activity of the cyclin B1 and cyclin D1 promoters, we
PCR-ampli¢ed both promoters for subcloning into pGL3-Ba-
sic (Promega) upstream of the ¢re£y luciferase-coding sequen-
ces.
Each of the cyclin promoter-luciferase reporters plus pRL-
SV40 (internal control) was transfected into WINH21 and
WINH25, the dox-inducible lines with lower FoxM1 basal
levels (see Fig. 1). After transfection, cells were treated with
dox to stimulate FoxM1 over-expression and the e¡ect on
promoter activity was monitored using luciferase assays.
When dox concentration was increased from 0 to 8 Wg/ml, a
gradual increase in cyclin B1 promoter activity was detected
(Fig. 6A,C). At 8 Wg/ml of dox, there was a 1.65-fold and
1.96-fold increase in cyclin B1 promoter activity in WINH21
and WINH25, respectively, when compared with the no dox
controls. The cyclin D1 reporter did not show any increase in
promoter activity when subjected to similar analysis (Fig.
6B,D); the di¡erence in cyclin D1 response between the two
lines may be due to clonal variation.
To further assess the activating e¡ect of FoxM1 on cyclin
B1 promoter activity, a CMV-driven FoxM1 expression plas-
mid, pcDNA3-FoxM1, was also co-transfected with the indi-
vidual cyclin reporters into NIH3T3 cells. A dramatic stimu-
lation of cyclin B1 reporter activity was observed with
increasing amounts of the FoxM1 expression plasmid (Fig.
6E). The increase leveled o¡ with 45 ng pcDNA3-FoxM1
and at greater than 45 ng a 2-fold stimulation of cyclin B1
promoter activity is similar in magnitude to the activating
e¡ect of L-catenin on cyclin D1 promoter activity [23].
When similarly assayed, activity of the cyclin D1 reporter
did not show any FoxM1 dependency (Fig. 6F). Taken to-
gether, these ¢ndings show that FoxM1 over-expression en-
hances cyclin B1 expression by stimulating the cyclin B1 pro-
moter.
3.7. FoxM1-dependent activation of the cyclin B1 promoter
does not require intact CDE and CHR elements
Transcription of human cyclin B1 is regulated by two pro-
moters, which direct constitutive and G2/M-stimulated ex-
pression of the gene [9,10]. Hwang et al. [10] identi¢ed a
65-bp region between the constitutive and G2/M-activated
transcriptional start sites that is important for directing
G2/M-stimulated cyclin B1 transcription. Within this 65-bp
sequence, di¡erent cis-acting elements including the CCAAT
box, CDE and CHR elements and GGCT repeats were shown
to be important for cyclin B1 promoter activity (Fig. 7A)
[10,24,25]. The CDE and CHR elements mediate the repres-
sive e¡ect of a p53-dependent, DNA damage-activated path-
way on cyclin B1 transcription [25] and are also present in the
promoters of cyclin A, cdc25C and cdc2 genes [26].
To determine whether FoxM1 activation of the cyclin B1
Fig. 6. FoxM1 over-expression stimulates cyclin B1 promoter activity. A^D: Over-expression by dox induction. WINH21 (A,B) and WINH25
(C,D) cells were transfected with luciferase reporters driven by cyclin B1 (A,C) or cyclin D1 (B,D) promoters. 16 h after transfection, cells were
treated with dox at di¡erent concentrations (0^8 Wg/ml). Luciferase assay was performed as described in Section 2 24 h (A,B) or 9 h (C,D) after
dox treatment. Reporter gene activity was expressed as a ratio of ¢re£y luciferase activity to control Renilla luciferase activity. E,F: Over-ex-
pression by transient co-transfection. NIH3T3 cells were transfected with di¡erent amounts of pcDNA3-FoxM1 plus either the cyclin B1 (E) or
cyclin D1 (F) luciferase reporter. pcDNA3 was added to normalize the amount of pcDNA3 vectors across all transfections. Luciferase assay
was performed 48 h after transfection as described in Section 2. Results shown are the means þ S.E.M. of triplicate cultures.
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promoter is mediated through the CDE and CHR elements,
we scrambled the CDE/CHR sites and £anking sequences by
PCR-based site-directed mutagenesis to generate promoter
Mutants 1, 2 and 3 (Fig. 7A). Consecutive 16-bp sequences
were substituted in these three mutants, with Mutant 2 cover-
ing the CDE/CHR sites. These mutant reporter constructs
were individually co-transfected with pRL-SV40 (internal con-
trol) and di¡erent amounts of pcDNA3-FoxM1 into HeLa
cells to test for their responsiveness to FoxM1 stimulation.
Interestingly, the FoxM1-dependent activating e¡ect could
still be observed when CDE/CHR sites were substituted in
Mutant 2 (Fig. 7B), strongly suggesting that promoter activa-
tion is not mediated by de-repression through the CDE and
CHR elements. However, the dose-dependent activating e¡ect
of FoxM1 was abolished in both Mutants 1 and 3 (Fig. 7B).
This implies that sequences substituted in Mutants 1 and 3,
including the CCAAT box and GGCT repeats, are necessary
for FoxM1 to exert its activating e¡ect. Transfection into
NIH3T3 cells gave similar results (data not shown).
4. Discussion
Mutation of the FoxM1 gene in mice revealed a cell cycle
defect only in heart and liver cells although FoxM1 is ex-
pressed broadly in all cycling cells. To study whether
FoxM1 plays a wider role in cell cycle regulation, an inducible
gain-of-function approach was undertaken to investigate
FoxM1 function in HeLa cells. Using multiple dox-inducible
HeLa lines, we showed that FoxM1 over-expression facilitates
growth recovery after serum deprivation and shortens transi-
tion through the G2/M phase of the cell cycle. Based on
further bivariate £ow analysis and Western and Northern
blot analyses, FoxM1 over-expression was found to be asso-
ciated with increased cyclin B1 expression. Further, we have
shown that FoxM1 as a transcription factor activates the cy-
clin B1 promoter in transient reporter assays and this activat-
ing e¡ect does not require the CDE/CHR sites within the
human cyclin B1 promoter. The stimulatory e¡ect of
FoxM1 on cyclin B1 promoter activity is in support of
FoxM1 playing a G2/M regulatory role.
The growth stimulatory e¡ect of FoxM1 over-expression is
reminiscent of the accelerated regeneration of hepatocytes in
transgenic mice over-expressing FoxM1b/HFH-11B in liver
[19]. In this animal model, growth stimulation of hepatocytes
was only evident upon partial hepatectomy when mitogenic
signals were generated. In contrast, signi¢cant growth stimu-
lation became detectable in our cell-based system only upon
serum deprivation. We argue that requirement for FoxM1
function is not limiting in the presence of serum when mito-
genic factors are abundant. Upon serum removal and subse-
quent decrease in mitogenic signals, FoxM1 function within
cells becomes limiting and the cell cycle e¡ect of FoxM1 over-
expression manifested. Our observation corroborates the no-
tion that FoxM1 requires activation by mitogenic signals to
Fig. 7. FoxM1-dependent stimulation of cyclin B1 promoter activity does not require the CDE and CHR elements. A: Structure of the wild-
type [10] and mutant cyclin B1 promoters. Consecutive 16-bp sequences (+11 to +26, +27 to +42, +43 to +58) were scrambled in Mutants 1, 2
and 3 to destroy the CCAAT box, CDE and CHR elements, and GGCT repeats, respectively. EcoRI sites were introduced into the mutant se-
quences to assist identi¢cation of mutant clones. B: Luciferase assay of mutant reporters. HeLa cells were transfected with luciferase reporters
driven by the di¡erent mutant cyclin B1 promoters and increasing amounts of pcDNA3-FoxM1. pcDNA3 was added to normalize the amount
of pcDNA3 vectors across all transfections. Luciferase assay was performed 48 h after transfection as described in Section 2. Reporter gene ac-
tivity was expressed as a ratio of ¢re£y luciferase activity to control Renilla luciferase activity. Results shown are the means þ S.E.M. of tripli-
cate cultures.
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function. In the transgenic analysis, it was argued that height-
ened FoxM1b expression led to earlier S and M phase entry.
Our demonstration that FoxM1 over-expression can activate
cyclin B1 expression and shorten G2/M transition strongly
supports earlier M phase entry upon FoxM1 induction.
In our study, FoxM1 over-expression by both dox induc-
tion of integrated transgenes and transient co-transfection led
to increase in cyclin B1 promoter activity. The fact that
FoxM1 levels peak in cells during G2/M and the observation
that high cyclin B1 levels are always associated with high
FoxM1 levels in cells examined by immunocytochemical
methods (Yao et al., unpublished data) are consistent with
FoxM1 being a regulator of cyclin B1 level in vivo. It is
interesting to note that FoxM1 activation of the cyclin B1
promoter does not require the CDE/CHR sites, which were
shown to mediate a negative e¡ect on cyclin B1 promoter
activity. Our current focus is to determine how FoxM1 acts
on the cyclin B1 promoter by further mutagenesis and DNA
binding analysis, and to test whether FoxM1 stimulation of
cyclin B1 promoter activity is cell cycle-dependent. Further
promoter analysis will also reveal the functional relationship
between FoxM1 and other pathway(s) in regulating cyclin B1
promoter activity.
Transcriptional regulation of cyclins has been intensively
studied in yeast. Yeast Fkh2, a forkhead transcription factor,
was recently demonstrated to activate transcription of the
major mitotic cyclin Clb2 and many other co-regulated genes
within the ‘CLB2’ cluster [7,8]. Transcription of genes within
the ‘CLB2’ cluster is cell cycle-regulated and peaks at G2/M.
We speculate that FoxM1, as a forkhead transcription factor
that shows peak expressions at G2/M and activates mitotic
cyclin expression, may be the mammalian equivalent of yeast
Fkh2 and thus may play a wider role in coordinating cell
cycle-dependent transcriptional periodicities. Recently, ge-
nome wide analysis of gene expression using cDNA micro-
arrays has revealed that, in addition to cyclins, many other
genes are periodically transcribed. From 6 to 12% of all genes
show cell cycle-dependent periodicity in yeast [27,28] while 6%
of 8600 human transcripts analyzed display cell cycle-depen-
dent variation in gene expression following serum stimulation
of human ¢broblasts [29]. These ¢ndings re£ect the molecular
complexity of cell cycle regulation at the transcriptional level
and illustrate the challenge of understanding how transcrip-
tion factors coordinate cell cycle-dependent periodicities. Ex-
pression pro¢ling using the FoxM1-inducible cell lines will
reveal how extensive a role FoxM1 plays in the regulation
of cell cycle periodicities.
Based on phylogenetic analysis, the M, N and O classes of
Fox factors are much more closely related to one another
than to the A^K classes [13]. It is interesting to note that
over-expression of members of the O subclass of Fox factors
(AFX, FKHR and FKHR-L1) was recently shown to mediate
G1 arrest by activating p27kip1 expression [30]. Another mem-
ber of the N class, CHES1, was demonstrated to complement
a G2 checkpoint defect in yeast [31]. It will be worth examin-
ing whether FoxM1, which is required for proper cell cycle
function, is actually involved in the regulation of the G2
checkpoint.
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